• OPEN AN ACCOUNT
Indian Indices
Sensex
74,314.59 -21.86
( -0.03%)
Global Indices
Nasdaq
51,493.09 -621.02
(-1.19%)
Dow Jones
7,573.47 -33.26
(-0.44%)
Hang Seng
63,960.24 37.24
(0.06%)
Nikkei 225
10,816.25 127.78
(1.20%)
Forex
USD-INR
95.42 0.14
(0.14%)
EUR-INR
110.10 0.01
(0.01%)
GBP-INR
128.62 0.03
(0.02%)
JPY-INR
0.62 0.00
(-0.26%)

EQUITY - MARKET SCREENER

AvenuesAI Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
539807
INE483S01020
12.175097
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CCAVENUE
49.48
5351.2
EPS(TTM)
Face Value()
Div & Yield %
0.31
1
0
 

Nath Bio-Genes (India) reports consolidated net loss of Rs 0.01 crore in the March 2026 quarter
May 05,2026
Net loss of Nath Bio-Genes (India) reported to Rs 0.01 crore in the quarter ended March 2026 as against net profit of Rs 1.48 crore during the previous quarter ended March 2025. Sales declined 0.73% to Rs 51.59 crore in the quarter ended March 2026 as against Rs 51.97 crore during the previous quarter ended March 2025.

For the full year,net profit rose 7.85% to Rs 41.63 crore in the year ended March 2026 as against Rs 38.60 crore during the previous year ended March 2025. Sales rose 21.98% to Rs 445.10 crore in the year ended March 2026 as against Rs 364.91 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales51.5951.97 -1 445.10364.91 22
OPM %8.680.81 -11.7813.64 -
PBDT2.262.91 -22 44.2643.86 1
PBT1.231.57 -22 40.2940.04 1
NP-0.011.48 PL 41.6338.60 8